Promising Therapeutic Impact of a Selective Estrogen Receptor Downregulator, Fulvestrant, as Demonstrated In Vitro upon Low-Grade Serous Ovarian Carcinoma Cell Lines

Few studies have reported hormonal agent use in the treatment of low-grade serous ovarian carcinomas (LGSOCs), which are chemoresistant. Considering the need for novel effective therapies, we investigated the hormone receptor expression and hormonal inhibition efficacy in LGSOCs. Using immunohistoch...

Descripción completa

Detalles Bibliográficos
Autores principales: Shanta, Kamrunnahar, Nakayama, Kentaro, Hossain, Mohammad Mahmud, Razia, Sultana, Ishibashi, Tomoka, Ishikawa, Masako, Yamashita, Hitomi, Kanno, Kosuke, Sato, Seiya, Nakayama, Satoru, Otsuki, Yoshiro, Kyo, Satoru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221871/
https://www.ncbi.nlm.nih.gov/pubmed/35735430
http://dx.doi.org/10.3390/curroncol29060321

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221871/
https://www.ncbi.nlm.nih.gov/pubmed/35735430
http://dx.doi.org/10.3390/curroncol29060321

Ejemplares similares